Last reviewed · How we verify
Arrevus Inc. — Portfolio Competitive Intelligence Brief
0 marketed
0 filed
0 Phase 3
2 Phase 2
0 Phase 1
Live · 30-min refresh
Portfolio leaders (marketed + Phase 3 / filed)
Therapeutic area mix
- Infectious disease · 1
- Oncology · 1
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Competitive overlap (companies sharing drug classes)
- Ain Shams Maternity Hospital · 1 shared drug class
- Akeso · 1 shared drug class
- Amgen · 1 shared drug class
- Coherus Oncology, Inc. · 1 shared drug class
- Hospital de Clinicas de Porto Alegre · 1 shared drug class
- Immatics US, Inc. · 1 shared drug class
- Jiangsu Famous Medical Technology Co., Ltd. · 1 shared drug class
- University of Heidelberg Medical Center · 1 shared drug class
Subscribe to ongoing alerts
Every new pipeline event for Arrevus Inc.:
- Arrevus Inc. pipeline updates — RSS
- Arrevus Inc. pipeline updates — Atom
- Arrevus Inc. pipeline updates — JSON
Cite this brief
Drug Landscape (2026). Arrevus Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/arrevus-inc. Accessed 2026-06-09.